Calamos Advisors LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$74.73 - $90.69 $8.22 Million - $9.98 Million
-110,000 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$72.61 - $90.2 $5.37 Million - $6.67 Million
74,000 Added 205.56%
110,000 $9.65 Million
Q3 2020

Oct 26, 2020
SELL
$71.87 - $131.03 $862,440 - $1.57 Million
-12,000 Reduced 25.0%
36,000 $2.74 Million
Q2 2020

Jul 27, 2020
BUY
$79.55 - $124.22 $3.82 Million - $5.96 Million
48,000 New
48,000 $5.92 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email